Transmission of mumps virus from mumps-vaccinated individuals to close contacts.

Municipal Health Service "Midden-Nederland", Zeist, The Netherlands.
Vaccine (Impact Factor: 3.49). 11/2011; 29(51):9551-6. DOI: 10.1016/j.vaccine.2011.09.100
Source: PubMed

ABSTRACT During a recent mumps epidemic in the Netherlands caused by a genotype D mumps virus strain, we investigated the potential of vaccinated people to spread mumps disease to close contacts. We compared mumps viral titers of oral fluid specimens obtained by quantitative PCR from vaccinated (n=60) and unvaccinated (n=111) mumps patients. We also investigated the occurrence of mumps infection among the household contacts of vaccinated mumps patients. We found that viral titers are higher for unvaccinated patients than for vaccinated patients during the 1st 3 days after onset of disease. While no symptomatic cases were reported among the household contacts (n=164) of vaccinated mumps patients (n=36), there were cases with serological evidence of asymptomatic infection among vaccinated household contacts (9 of 66 vaccinated siblings). For two of these siblings, the vaccinated index patient was the most probable source of infection. We conclude that, in this particular outbreak, the risk of a close contact becoming infected by vaccinated patients was small, but present.

  • [Show abstract] [Hide abstract]
    ABSTRACT: In 2009-2010, we investigated a mumps outbreak among a highly vaccinated Orthodox Jewish population in a village in Orange County (OC), New York, to identify risk factors associated with mumps transmission among persons with two doses of mumps-containing vaccine. Demographic and epidemiologic characteristics were collected on students in grades 6-12 in three schools. A mumps case was defined as a student, who self-reported parotitis, orchitis, jaw swelling, and/or a mumps-related complication or whose mumps illness was reported to the OC Health Department during September 1, 2009-January 18, 2010. Log-binomial regression analyses were conducted separately for boys and girls as they attended different schools and had different hours of study. Of the 2503 students with two documented doses of mumps-containing vaccine, 320 (13%) developed mumps. Risk of mumps increased with increasing number of mumps cases in the class [≥8versus ≤3 cases: boys aRR=3.1 (95% CI: 2.0-5.0); girls aRR=2.6 (95% CI: 1.6-4.1)] and household [>1 versus 0 cases: boys aRR=4.3 (95%CI: 3.7-5.6); girls aRR=10.1 (95%CI: 7.1-14.3)]. Age at first dose, time since last dose, time between first and second dose, school, class size, number of hours at school per week, and household size were not significantly associated with having mumps. Two doses of mumps-containing vaccine may not be as effective in outbreak settings with multiple, prolonged, and intense exposure. Additional studies are required to understand why such mumps outbreaks occur and how they can be prevented in the future.
    The Pediatric Infectious Disease Journal 08/2013; · 3.14 Impact Factor
  • The Pediatric Infectious Disease Journal 10/2013; 32(10):1156-7. · 3.14 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: SUMMARY Mumps outbreaks in highly vaccinated populations with genotype G have been reported repeatedly. Detection of these outbreaks can be difficult in a setting with relatively high vaccination coverage when acute cases of mumps are routinely diagnosed by IgM serology since this marker is not reliable for diagnosis of mumps re-infection. To learn whether diagnostic tests performed in a large private laboratory may be useful to detect mumps outbreaks retrospectively, we reviewed the results of almost 7000 mumps tests. Two groups were compared: group 1 comprised of 3438 samples from patients submitted by physicians and clinicians (it was assumed that these patients visited their doctor due to acute disease). Group 2 comprised of 3398 samples submitted from company medical officers and occupational physicians. Since these patients usually attend for routine check-ups and certification of immunity to vaccine-preventable diseases, these samples comprised a control group. From July 2010 to May 2011, a mumps virus outbreak with more than 300 cases occurred in Bavaria, Southeast Germany. Our study includes samples received for serological mumps tests from January 2009 until December 2011 (36 months). The two groups were analysed with regard to the number of IgM-positive cases per month and the level of IgG titre. We found a marked increase for both parameters in group 1 during the time of the outbreak, while the samples submitted by the occupational medical physicians did not display significant alterations. These parameters reflect the outbreak with high accuracy, indicating that a retrospective analysis of IgG titres may be a useful tool for detection of mumps outbreaks when, as was the case in Germany, (i) a nationwide notification system has not been implemented and (ii) a highly vaccinated population is affected.
    Epidemiology and Infection 01/2014; · 2.49 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014